CN108291207A - 神经前体细胞群体及其用途 - Google Patents

神经前体细胞群体及其用途 Download PDF

Info

Publication number
CN108291207A
CN108291207A CN201680071312.9A CN201680071312A CN108291207A CN 108291207 A CN108291207 A CN 108291207A CN 201680071312 A CN201680071312 A CN 201680071312A CN 108291207 A CN108291207 A CN 108291207A
Authority
CN
China
Prior art keywords
cell
cells
neural precursor
enriched
neural
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201680071312.9A
Other languages
English (en)
Chinese (zh)
Inventor
科里·尼古拉斯
路易斯·富恩蒂尔巴
童卓卡
玛丽娜·伯施泰恩
索尼娅·克里克斯
斯图尔特·钱伯斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neuron Therapy Co
Original Assignee
Neuron Therapy Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuron Therapy Co filed Critical Neuron Therapy Co
Publication of CN108291207A publication Critical patent/CN108291207A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • C12N5/0619Neurons
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • C12N5/0623Stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
CN201680071312.9A 2015-10-08 2016-10-10 神经前体细胞群体及其用途 Pending CN108291207A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562239042P 2015-10-08 2015-10-08
US62/239,042 2015-10-08
PCT/US2016/056316 WO2017062971A1 (en) 2015-10-08 2016-10-10 Neural precursor cell populations and uses thereof

Publications (1)

Publication Number Publication Date
CN108291207A true CN108291207A (zh) 2018-07-17

Family

ID=57200130

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201680071312.9A Pending CN108291207A (zh) 2015-10-08 2016-10-10 神经前体细胞群体及其用途

Country Status (8)

Country Link
US (1) US20180369287A1 (https=)
EP (1) EP3359647A1 (https=)
JP (4) JP2018529389A (https=)
CN (1) CN108291207A (https=)
AU (3) AU2016335563B2 (https=)
CA (1) CA3001316A1 (https=)
HK (1) HK1258172A1 (https=)
WO (1) WO2017062971A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113826564A (zh) * 2021-08-31 2021-12-24 南通大学 一种检测小鼠运动能力的方法
CN114736957A (zh) * 2022-04-15 2022-07-12 中国人民解放军空军军医大学 外泌体介导rna casc15干预阿尔茨海默症突触损失的应用
CN117092354A (zh) * 2023-10-18 2023-11-21 亿航(苏州)生物医药有限公司 一种用于识别脑源性细胞的细胞外囊泡的蛋白标志物

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015069736A1 (en) 2013-11-08 2015-05-14 The Mclean Hospital Corporation METHODS FOR EFFICIENT GENERATION OF GABAergic INTERNEURONS FROM PLURIPOTENT STEM CELLS
JP2022043373A (ja) * 2018-12-28 2022-03-16 国立大学法人京都大学 大脳皮質細胞からのl1cam陽性細胞の取得およびその細胞製剤としての使用
US12343359B2 (en) 2019-05-23 2025-07-01 Dignity Health Inhibitory interneuron treatment methods, uses and compositions for diabetes
WO2023004345A1 (en) * 2021-07-21 2023-01-26 University Of Washington Compositions and methods for enhancing cardiomyocyte transplant engraftment
KR102684884B1 (ko) * 2021-08-05 2024-07-15 성균관대학교산학협력단 신경줄기세포의 줄기세포능 증진을 위한 gng2의 용도
CN118064356A (zh) * 2022-11-22 2024-05-24 浙江霍德生物工程有限公司 前脑神经前体细胞在治疗与前脑神经细胞的死亡和/或功能不全相关的疾病中的应用
WO2025075929A1 (en) * 2023-10-02 2025-04-10 Neurona Therapeutics Inc. Methods of treating seizure activity

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1894401A (zh) * 2003-03-12 2007-01-10 睿良思生命科学私人有限公司 从人胚胎干细胞衍生终末分化的多巴胺能神经元
CN101389290A (zh) * 2006-01-20 2009-03-18 加利福尼亚大学董事会 神经细胞的移植
WO2014153230A1 (en) * 2013-03-14 2014-09-25 The Regents Of The University Of California In vitro production of medial ganglionic eminence precursor cells

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
WO2001088104A2 (en) 2000-05-17 2001-11-22 Geron Corporation Neural progenitor cell populations
EP2298867A3 (en) 2000-06-20 2013-01-16 ES Cell International Pte Ltd. Method of controlling differentiation of embryonic stem (ES) cells by culturing ES cells in the presence of bmp-2 pathway antagonists
JPWO2004005496A1 (ja) 2002-07-05 2005-11-04 麒麟麦酒株式会社 臍帯血、骨髄、末梢血等に含まれる新規な未分化幹細胞集団
US20060211111A1 (en) 2002-12-18 2006-09-21 Maisam Mitalipova Compositions and methods for neural cell production and stabilization
US20070020608A1 (en) 2003-05-08 2007-01-25 Peter Eriksson Method for the generation of neural progenitor cells
US7820439B2 (en) 2003-09-03 2010-10-26 Reliance Life Sciences Pvt Ltd. In vitro generation of GABAergic neurons from pluripotent stem cells
US7682828B2 (en) 2003-11-26 2010-03-23 Whitehead Institute For Biomedical Research Methods for reprogramming somatic cells
JP2008501320A (ja) 2004-06-02 2008-01-24 イーエス・セル・インターナショナル・プライヴェート・リミテッド 細胞保存方法
US20060008451A1 (en) 2004-07-06 2006-01-12 Michigan State University In vivo methods for effecting tissue specific differentiation of embryonic stem cells
EP1814979B1 (en) * 2004-11-17 2015-04-08 Neuralstem, Inc. Transplantation of human neural cells for treatment of neurodegenerative conditions
EP1856248A4 (en) 2005-02-09 2010-01-20 Burnham Inst Medical Research HOMOGENEOUS NEURALE CURRENT CELLS
WO2006091766A2 (en) 2005-02-24 2006-08-31 Jau-Nan Lee Human trophoblast stem cells and use thereof
US7803364B2 (en) 2005-11-17 2010-09-28 The Cleveland Clinic Foundation Multipotent neural stem cells
WO2007067280A2 (en) 2005-12-08 2007-06-14 University Of Louisville Research Foundation, Inc. Very small embryonic-like (vsel) stem cells and methods of isolating and using the same
ES2663875T3 (es) 2006-11-03 2018-04-17 Multiple Sclerosis Research Center Of New York Células madre mesenquimáticas derivadas de la médula ósea como fuente de progenitores neurales
EP2607477B1 (en) 2007-05-03 2020-09-23 The Brigham and Women's Hospital, Inc. Multipotent stem cells and uses thereof
US8574567B2 (en) 2007-05-03 2013-11-05 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
US20100287638A1 (en) 2007-10-01 2010-11-11 The Hospital For Sick Children Neural tumor stem cells and methods of use thereof
US20110165129A1 (en) 2008-05-06 2011-07-07 Arnold Kriegstein Ameliorating Nervous Systems Disorders
WO2010144696A1 (en) 2009-06-11 2010-12-16 Burnham Institute For Medical Research Directed differentiation of stem cells
KR20110015739A (ko) 2009-08-10 2011-02-17 삼성전자주식회사 Emi방사 저감을 위한 플라즈마 디스플레이 장치
WO2011079307A2 (en) 2009-12-23 2011-06-30 The Salk Institute For Biological Studies Methods and compositions for treating neurological disorders
WO2011091048A1 (en) 2010-01-19 2011-07-28 The Board Of Trustees Of The Leland Stanford Junior University Direct conversion of cells to cells of other lineages
CA2835215C (en) * 2011-05-18 2023-10-10 The Regents Of The University Of California Non-immortal human retinal cell compositions, method for preparing them, and their use for treating retinal diseases
WO2013076726A1 (en) 2011-11-21 2013-05-30 Ramot At Tel-Aviv University Ltd. Stem cell-derived neural cells for cell therapy in neurological disorders
KR101429217B1 (ko) 2012-02-06 2014-08-12 동국대학교 산학협력단 줄기세포를 신경세포로 분화시키는 방법
WO2013139429A1 (en) 2012-03-21 2013-09-26 Merck Patent Gmbh Induced neural stem cells
WO2013155222A2 (en) 2012-04-10 2013-10-17 The Regents Of The University Of California Brain-specific enhancers for cell-based therapy
JP2014082956A (ja) 2012-10-19 2014-05-12 Somar Corp 細胞培養基材、およびそれを用いた細胞培養方法並びに多能性幹細胞の分化誘導方法
EP3498824A1 (en) 2013-04-26 2019-06-19 Memorial Sloan-Kettering Cancer Center Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells
CN106164255B (zh) 2013-09-20 2020-02-14 隆萨有限公司 细胞的核重编程的方法
WO2015069736A1 (en) 2013-11-08 2015-05-14 The Mclean Hospital Corporation METHODS FOR EFFICIENT GENERATION OF GABAergic INTERNEURONS FROM PLURIPOTENT STEM CELLS

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1894401A (zh) * 2003-03-12 2007-01-10 睿良思生命科学私人有限公司 从人胚胎干细胞衍生终末分化的多巴胺能神经元
CN101389290A (zh) * 2006-01-20 2009-03-18 加利福尼亚大学董事会 神经细胞的移植
WO2014153230A1 (en) * 2013-03-14 2014-09-25 The Regents Of The University Of California In vitro production of medial ganglionic eminence precursor cells

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BING ZHU 等: "CXCL12 Enhances Human Neural Progenitor Cell Survival Through a CXCR7- and CXCR4-Mediated Endocytotic Signaling Pathway", 《STEM CELLS》 *
CHEN ET AL.: "Use of "MGE Enhancers" for Labeling and Selection of Embryonic Stem Cell-Derived Medial Ganglionic Eminence (MGE) Progenitors and Neurons", 《PLOS ONE》 *
NICHOLAS ET AL.: "Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development", 《CELL STEM CELL》 *
马献昆 等: "成人脑神经干细胞体内外增殖、分化和迁移研究", 《中华神经外科疾病研究杂志》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113826564A (zh) * 2021-08-31 2021-12-24 南通大学 一种检测小鼠运动能力的方法
CN114736957A (zh) * 2022-04-15 2022-07-12 中国人民解放军空军军医大学 外泌体介导rna casc15干预阿尔茨海默症突触损失的应用
CN114736957B (zh) * 2022-04-15 2024-03-12 中国人民解放军空军军医大学 外泌体介导rna casc15干预阿尔茨海默症突触损失的应用
CN117092354A (zh) * 2023-10-18 2023-11-21 亿航(苏州)生物医药有限公司 一种用于识别脑源性细胞的细胞外囊泡的蛋白标志物
CN117092354B (zh) * 2023-10-18 2023-12-29 亿航(苏州)生物医药有限公司 一种用于识别脑源性细胞的细胞外囊泡的蛋白标志物

Also Published As

Publication number Publication date
JP2025022948A (ja) 2025-02-14
JP2018529389A (ja) 2018-10-11
AU2025283558A1 (en) 2026-01-15
HK1258172A1 (zh) 2019-11-08
US20180369287A1 (en) 2018-12-27
EP3359647A1 (en) 2018-08-15
JP2022169768A (ja) 2022-11-09
JP7138959B2 (ja) 2022-09-20
CA3001316A1 (en) 2017-04-13
JP7598655B2 (ja) 2024-12-12
AU2023200389A1 (en) 2023-02-23
AU2016335563A1 (en) 2018-05-24
AU2023200389B2 (en) 2025-09-25
AU2016335563B2 (en) 2022-10-27
WO2017062971A1 (en) 2017-04-13
JP2020202865A (ja) 2020-12-24

Similar Documents

Publication Publication Date Title
JP7138959B2 (ja) 神経前駆細胞集団を作出する方法
Nizzardo et al. Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model
Assinck et al. Myelinogenic plasticity of oligodendrocyte precursor cells following spinal cord contusion injury
Chen et al. CREB binding protein is required for both short-term and long-term memory formation
Corti et al. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model
ES2796853T3 (es) Diferenciación dirigida de astrocitos a partir de células madre pluripotentes humanas para uso en el cribado de medicamentos y el tratamiento de la esclerosis lateral amiotrófica (ELA)
KR20110011658A (ko) 최적화된 세포 제제에 의한 수초 질환의 치료
KR102203034B1 (ko) 중뇌 유래의 성상교세포와 도파민 신경줄기세포의 공동 이식에 의한 도파민 신경세포의 이식 치료 효과 개선
Poltavtseva et al. Evaluation of progenitor cell cultures from human embryos for neurotransplantation
Olstorn et al. Transplantation of stem cells from the adult human brain to the adult rat brain
Nizzardo et al. iPSC-derived LewisX+ CXCR4+ β1-integrin+ neural stem cells improve the amyotrophic lateral sclerosis phenotype by preserving motor neurons and muscle innervation in human and rodent models
CN112368004A (zh) 细胞组合物和其用途
Aleksandrova et al. Behavior of human neural progenitor cells transplanted to rat brain
US20240207324A1 (en) Method for quality control and enrichment of human dopaminergic neural precursor cells
US20170095512A1 (en) Methods of inducing myelination and maturation of oligodendrocytes
Fitzpatrick et al. Cell-based therapies for Parkinson's disease: past, present, and future
TW201536918A (zh) 從人類滋養層幹細胞中生成神經幹細胞
Hattiangady et al. Neural stem cell grafting in an animal model of chronic temporal lobe epilepsy
US20080226609A1 (en) Transplantation of Glial Restricted Precursor-Derived Astrocytes for Promotion of Axon Growth
Jaberi et al. Transplanted autologous neural stem cells show promise in restoring motor function in monkey spinal cord injury
Esmaeilzade et al. Adult neurogenesis of epidermal neural crest stem cells (EPI-NCSC) in hippocampus of Alzheimer's rat model
WO2025075929A1 (en) Methods of treating seizure activity
KR101646722B1 (ko) 인간 복측 종뇌 유래 신경줄기세포를 유효성분으로 포함하는 간질의 예방, 개선 또는 치료용 약제학적 조성물
Terpstra et al. Re-evaluation of systemic proteasome inhibition as an animal model for Parkinson's disease
Li Role of Tyrosine Receptor Kinase B in the Development and Function of the Central Nervous System

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1258172

Country of ref document: HK